Evidence map›Paper›PMID 35052591›Full record

ReviewAntioxidants (Basel, Switzerland)2021

Allicin, an Antioxidant and Neuroprotective Agent, Ameliorates Cognitive Impairment.

Muhammad Shahid Nadeem, Imran Kazmi, Inam Ullah, Khushi Muhammad, Firoz Anwar

Open access · goldAbstract readReview
In one paragraph

Review in Antioxidants (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed
14.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

46 citing papers in PubMed, 110 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Organosulfur Compounds: Potential Therapeutics for Parkinson's Disease.CNS & neurological disorders drug targets · 2026
    Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. The Impact of Allicin on the Growth ofAnimals : an open access journal from MDPI · 2025
    Article
  18. Article
  19. Lebanese Medicinal Plants with Ophthalmic Properties.Pharmaceuticals (Basel, Switzerland) · 2025
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Muhammad Shahid NadeemDepartment of Biochemistry, Faculty of Science, King Abdulaziz University, Jeddah 21589, Saudi Arabia.ORCID 0000-0003-4112-0925
Imran KazmiDepartment of Biochemistry, Faculty of Science, King Abdulaziz University, Jeddah 21589, Saudi Arabia.ORCID 0000-0003-1881-5219
Inam UllahDepartment of Biotechnology and Genetic Engineering, Hazara University, Mansehra 21300, Pakistan.
Khushi MuhammadDepartment of Biotechnology and Genetic Engineering, Hazara University, Mansehra 21300, Pakistan.
Firoz AnwarDepartment of Biochemistry, Faculty of Science, King Abdulaziz University, Jeddah 21589, Saudi Arabia.
King Abdulaziz University · SAHazara University · PK

Funding

Ministry of Education, Saudi Arabia IFPRP -236 -130-1442
6 · The paper itself

Abstract

Allicin (diallylthiosulfinate) is a defense molecule produced by cellular contents of garlic (

Indexed as

allicinantioxidantbiosynthesiscognitive impairmentgarlicneuroprotectivetherapeutic

Identifiers

PMID35052591
PMCPMC8772758
OpenAlexW4205626788

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.